Vital Signs - Stay Connected


Regular Price: USD 1,500.00

Special Price USD 1,050.00

30% OFF

* Required Fields

Regular Price: USD 1,500.00

Special Price USD 1,050.00


Be the first to review this product

This issue of Vital Signs, released on November 27, 2006, provides a Q&A session with Gerry Purdy, VP and Chief Analyst, Information and Communication Technologies, on the use of wireless communications in the pharmaceutical sector. Additionally, an emerging company profile is provided for MannKind Corporation, a leader in pulmonary insulin product development. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of November 13 - November 17, 2006.

Table of Contents

Vital Signs - Stay ConnectedVital Signs: 27 November 2006This week's issue:

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.